Series of quinazoline sugar derivatives used as protein tyrosine kinase inhibitor, preparation method and application thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- OCEAN UNIV OF CHINA
- Publication Date
- 2010-10-13
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field The invention relates to a class of tyrosine kinase inhibitors, in particular to a series of sugar derivatives based on quinazoline parent rings, their preparation methods and their application in the preparation of antitumor drugs. Background technique Targeted therapy is a treatment that uses specific genes or gene expression products that can be expressed by tumor cells but rarely or not expressed by normal cells to form relative or absolute targeting to kill tumor cells to the greatest extent while causing little damage to normal cells method. Tyrosine kinases are a class of transmembrane proteins, enzymes that catalyze the transfer of a phosphate group from ATP to a tyrosine residue located on a protein substrate. Plays an important role in normal cell growth. The epidermal growth factor receptor (EGFR) in the tyrosine kinase family has been identified as an essential enzyme in the process of cell growth and reproduction. In most tumors, the epidermal ...